Randox: Qnostics SARS-CoV-2 Molecular Controls
Randox has launched whole pathogen molecular controls for SARS-CoV-2. The controls were developed by UK scientists and are being made available by Randox under the Qnostics brand name. The controls are for use to ensure accurate coronavirus test and system performance and are manufactured using whole pathogens to mimic the patient sample. The controls contain the entire SARS-COV-2 genome, incuding conserved regions recommended by the US Centers for Disease Control and Prevention and the World Health Organization, and they are compatible for use with commercial and in-house testing methods.